BOSTON–( COMPANY CABLE)– Myomo, Inc. (NYSE American: MYO) (” Myomo”), a wearable clinical robotics business that provides raised performance for those dealing with neurological conditions and top arm or leg paralysis, today revealed that it has actually valued an underwritten public offering of 3,000,000 shares of its ordinary shares at a public offering cost of $5.00 per share. Myomo anticipates the gross earnings from this supplying to be roughly $15.0 million, prior to subtracting the underwriting discount rate
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/myomo-inc-prices-15-0-million-public-offering-of-common-stock/
